Immunogenicity of HLA-DR1 Restricted Peptides Derived from Leishmania major gp63 Using FVB/N-DR1 Transgenic Mouse Model
about
Post-Genomics and Vaccine Improvement for LeishmaniaVisceral Leishmaniasis: Advancements in Vaccine Development via Classical and Molecular ApproachesAn overview on Leishmania vaccines: A narrative review article.Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.
P2860
Immunogenicity of HLA-DR1 Restricted Peptides Derived from Leishmania major gp63 Using FVB/N-DR1 Transgenic Mouse Model
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunogenicity of HLA-DR1 Rest ...... B/N-DR1 Transgenic Mouse Model
@en
Immunogenicity of HLA-DR1 Rest ...... /N-DR1 Transgenic Mouse Model.
@nl
type
label
Immunogenicity of HLA-DR1 Rest ...... B/N-DR1 Transgenic Mouse Model
@en
Immunogenicity of HLA-DR1 Rest ...... /N-DR1 Transgenic Mouse Model.
@nl
prefLabel
Immunogenicity of HLA-DR1 Rest ...... B/N-DR1 Transgenic Mouse Model
@en
Immunogenicity of HLA-DR1 Rest ...... /N-DR1 Transgenic Mouse Model.
@nl
P2860
P1476
Immunogenicity of HLA-DR1 Rest ...... B/N-DR1 Transgenic Mouse Model
@en
P2093
P2860
P304
P577
2013-04-01T00:00:00Z